
Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 subvariant
(Reuters) -Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot...
18th November, 2022

(Reuters) -Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot...
18th November, 2022

By Jennifer Rigby and Emma Farge LONDON/GENEVA (Reuters) – Pharmaceutical companies could be made to...
18th November, 2022

By David Milliken LONDON (Reuters) – More than three quarters of British people who have suffered pe...
9th November, 2022

By Johann M Cherian (Reuters) -The FTSE 100 index dipped in choppy trading on Monday as GSK led a fa...
7th November, 2022

By Crystal Bethea, Owner — C3 Wellness Spa Although American veterans have automatic access to the D...
3rd November, 2022

By Natalie Grover (Reuters) -GSK beat third-quarter earnings forecasts on Wednesday and raised its 2...
2nd November, 2022

LONDON (Reuters) -London’s Ambulance Service will ballot its members on whether to carrying out stri...
11th October, 2022

LONDON (Reuters) -More than 300,000 members of Britain’s largest nursing union will begin voting on...
6th October, 2022

Diagnosis is a hugely emotional time for cancer patients. While there are the understandable worries...
5th October, 2022

By Professor Denis Kinane, Founding Scientist, Cignpost Diagnostics COVID had a dramatic and immedia...
26th September, 2022

FRANKFURT (Reuters) -An official at the European Union’s drugs regulator said on Tuesday the COVID-1...
20th September, 2022

By Ronny Shalev, PhD, CEO of Dyad Medical Artificial intelligence (AI) is one of the main tools powe...
16th September, 2022